Scholarlink

Purpose <p>To examine the clinical characteristics of Japanese older sarcopenic patients with heart failure (HF) diagnosed by the Asian Working Group for Sarcopenia 2025 (AWGS 2025) criteria.</p> Methods <p>The participants were patients with HF aged ≥ 65 years who required hospitalization. At discharge, when their condition was stable, the diagnosis of sarcopenia, laboratory measurements, and echocardiography were conducted, and the occurrence of all-cause and cardiovascular mortality and hospitalization after discharge was investigated. We investigated the association between sarcopenia diagnosed by AWGS 2025 and mortality risk.</p> Results <p>We recruited 253 patients (mean age, 82.2 years; male, 51.0%; BNP, 182.8 pg/dL). The prevalence of sarcopenia among all participants was 59.3% after adjusting for skeletal muscle mass using either method (53.8% after adjusting for height and 47.4% after adjusting for BMI). For BMI &lt; 22 or ≥ 25 kg/m<sup>2</sup>, the prevalence of sarcopenia differed depending on the skeletal muscle adjustment method. The log-rank tests showed that the AWGS 2025 criteria were significantly associated with all-cause and cardiovascular mortality. In the Cox proportional hazards analysis, after adjusting for age, sex, HF stage and prognostic factors for heart failure, the AWGS 2025 criteria were also associated with all-cause and cardiovascular mortality in patients with HF, irrespective of the adjustment methods.</p> Conclusion <p>Older patients with HF have a high rate of sarcopenia, and sarcopenia, as defined by the AWGS 2025 criteria, is associated with an increased mortality risk.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence, characteristics, and prognostic associations of sarcopenia in older adults with heart failure

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月23日

查看全文
  • Kakeru Hashimoto,
  • Akihiro Hirashiki,
  • Koki Kawamura,
  • Ikue Ueda,
  • Shigeharu Yamazaki,
  • Shunya Tanioku,
  • Takahiro Kamihara,
  • Hitoshi Kagaya,
  • Hidenori Arai,
  • Atsuya Shimizu

摘要

Purpose

To examine the clinical characteristics of Japanese older sarcopenic patients with heart failure (HF) diagnosed by the Asian Working Group for Sarcopenia 2025 (AWGS 2025) criteria.

Methods

The participants were patients with HF aged ≥ 65 years who required hospitalization. At discharge, when their condition was stable, the diagnosis of sarcopenia, laboratory measurements, and echocardiography were conducted, and the occurrence of all-cause and cardiovascular mortality and hospitalization after discharge was investigated. We investigated the association between sarcopenia diagnosed by AWGS 2025 and mortality risk.

Results

We recruited 253 patients (mean age, 82.2 years; male, 51.0%; BNP, 182.8 pg/dL). The prevalence of sarcopenia among all participants was 59.3% after adjusting for skeletal muscle mass using either method (53.8% after adjusting for height and 47.4% after adjusting for BMI). For BMI < 22 or ≥ 25 kg/m2, the prevalence of sarcopenia differed depending on the skeletal muscle adjustment method. The log-rank tests showed that the AWGS 2025 criteria were significantly associated with all-cause and cardiovascular mortality. In the Cox proportional hazards analysis, after adjusting for age, sex, HF stage and prognostic factors for heart failure, the AWGS 2025 criteria were also associated with all-cause and cardiovascular mortality in patients with HF, irrespective of the adjustment methods.

Conclusion

Older patients with HF have a high rate of sarcopenia, and sarcopenia, as defined by the AWGS 2025 criteria, is associated with an increased mortality risk.